Literature DB >> 21342029

The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?

Raffaele Addeo, Michele Caraglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21342029     DOI： 10.1586/era.10.190

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  3 in total

1.  Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy.

Authors:  Mette Linnert; Helle K Iversen; Julie Gehl
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

2.  Molecular aspects of breast cancer metastasis to the brain.

Authors:  Jodi M Saunus; Majid Momeny; Peter T Simpson; Sunil R Lakhani; Leonard Da Silva
Journal:  Genet Res Int       Date:  2011-11-29

3.  Activation of Neuregulin 1/ErbB Signaling Is Involved in the Development of TOCP-Induced Delayed Neuropathy.

Authors:  Hai-Yang Xu; Pan Wang; Ying-Jian Sun; Ming-Yuan Xu; Li Zhu; Yi-Jun Wu
Journal:  Front Mol Neurosci       Date:  2018-04-23       Impact factor: 5.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.